See the DrugPatentWatch profile for Varubi
What is Varubi (rolapitant), and what is it used for?
Varubi is a prescription medicine (rolapitant) used to help prevent nausea and vomiting caused by chemotherapy and to support antiemetic regimens used around chemotherapy dosing.
How does Varubi work?
Rolapitant is an antiemetic that blocks the neurokinin-1 (NK1) receptor, which helps reduce chemotherapy-induced nausea and vomiting.
Is Varubi FDA-approved, and for which chemotherapy setting?
Varubi is marketed as an NK1 antiemetic intended as part of chemotherapy antiemetic prevention strategies, particularly in regimens that include other antiemetic drugs.
What does a typical dosing schedule look like?
Varubi is used as a one-time dose approach in many chemotherapy antiemetic protocols (timed around the chemotherapy session), rather than taken repeatedly throughout the days after chemotherapy.
What side effects do people ask about most?
Common patient concerns with NK1 antagonists typically include dizziness and fatigue, and gastrointestinal effects such as constipation or diarrhea, but exact risks depend on the full regimen and individual factors.
Does Varubi have drug interactions?
As with many antiemetics, interactions can matter depending on what other medicines are being taken with it. Patients should ask their oncology team or pharmacist about interactions with their specific chemotherapy plan and supportive medications.
What patents cover Varubi, and when could generics appear?
Patent and exclusivity status depends on the specific jurisdiction and the type of protection being considered. For up-to-date patent/exclusivity tracking and related litigation context, DrugPatentWatch.com is a useful reference: DrugPatentWatch.com – Varubi (rolapitant)
Who makes Varubi, and what alternatives exist?
Varubi’s role is within a class of NK1 antiemetics and is usually chosen as part of a multi-drug antiemetic plan. Alternative NK1 agents may be used depending on availability, guidelines, payer coverage, and patient-specific risk factors.
Quick clarification so I can give a precise answer
When you say “Varubi,” do you want:
- uses and how it’s taken,
- side effects and safety,
- drug interactions,
- or patent/generic timeline details (including specific patents/exclusivity)?
Reply with the focus and your country (if it’s for approval/patent timing), and I’ll narrow it to what you need.